Glycosphingolipids are important constituents of cell membranes. The tremendous diversity of oligosaccharide structure and the number of glycosyltransferases necessary for synthesizing these structures suggest that they may have significant functions. As examples, they do function as human blood group allo- and autoantigens, as receptors for viruses and toxins, as tumor markers, and are involved in cell-cell interactions. Some of these functions, such as toxin binding and antigenicity, have been passively transferred to cells incubating the cells with the appropriate glycosphingolipid. Many tumor-associated glycosphingolipids have been described and some of these are shed by the tumor cells. Since some glycosphingolipids suppress immune responsiveness in vitro, glycosphingolipids shed from tumors may contribute to the immunosuppression found with some forms of human cancer. Glycosphingolipids form micelles in water since the monomers are virtually insoluble. Significant concentrations of glycosphingolipids are found in plasma and they are exclusively associated with lipoproteins. Little is known about the mechanisms by which glycosphingolipids enter plasma, whether by secretion, shedding from membranes, or absorption from cell membranes by lipoproteins. The ultimate goal of this proposal is to understand the mechanisms by which glycosphingolipids are secreted or shed from normal and malignant cells, interact with plasma lipoproteins, transfer between lipoproteins, and transfer from lipoproteins onto or into other cells. Human tumor cell lines will be used as models to study the secretion or shedding of glycosphingolipids and the role of lipoproteins in this process. Blood from various individuals with differing glycosphingolipid blood group antigens will be used to study the kinetics and mechanisms of transfer of glycosphingolipids between plasma lipoproteins and between lipoproteins and human erythrocytes, lymphocytes, and platelets. This work will lead to a better understanding of the way exogenous glycosphingolipids affect cell function and cell surface topography. It will also provide deeper insight into how lipoproteins interact with each other and with cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA045690-02
Application #
3458501
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1987-08-01
Project End
1992-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Griot-Wenk, M; Pahlsson, P; Chisholm-Chait, A et al. (1993) Biochemical characterization of the feline AB blood group system. Anim Genet 24:401-7
Blackall, D P; Ugorski, M; Smith, M E et al. (1992) The binding of human alloantibodies to recombinant glycophorin A. Transfusion 32:629-32
Remaley, A T; Ugorski, M; Wu, N et al. (1991) Expression of human glycophorin A in wild type and glycosylation-deficient Chinese hamster ovary cells. Role of N- and O-linked glycosylation in cell surface expression. J Biol Chem 266:24176-83
Burger, S R; Remaley, A T; Danley, J M et al. (1991) Stable expression of rabies virus glycoprotein in Chinese hamster ovary cells. J Gen Virol 72 ( Pt 2):359-67
Bhat, S; Spitalnik, S L; Gonzalez-Scarano, F et al. (1991) Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A 88:7131-4
Harouse, J M; Bhat, S; Spitalnik, S L et al. (1991) Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253:320-3
Platt, J L; Lindman, B J; Chen, H et al. (1990) Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 50:817-22
Jefferies, L C; Stevenson, F K; Goldman, J et al. (1990) Anti-idiotypic antibodies specific for a pathologic anti-Pr2 cold agglutinin. Transfusion 30:495-502
Spitalnik, P F; Danley, J M; Burger, S R et al. (1989) The glycosphingolipid composition of the human hepatoma cell line,Hep-G2. Arch Biochem Biophys 273:578-91
Snyder, P J; Bashey, H M; Montecinos, A et al. (1989) Secretion of multiple forms of human luteinizing hormone by cultured fetal human pituitary cells. J Clin Endocrinol Metab 68:1033-8